Atreca Presents Initial Clinical Data from Phase 1b Trial of ATRC-101 in Select Advanced Solid Tumors

NEXT STORY
AREV Signs Definitive Collaborative Development Agreement with Voynich Biosciences and Invites Richard van Breemen PhD to SAB
PREV STORY
Teleflex Announces Quarterly Dividend
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

PharmaCyte Biotech to Present Clinical Trial at Marcum MicroCap, ASCO and BIO International Conferences

SILVER SPRING, Md., May 26, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a ...

author_avatar
NASDAQ Market News

AngioDynamics to Present at the Barclays Global Healthcare Conference

ALBANY, N.Y., March 08, 2017 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of ...

author_avatar
NASDAQ Market News

IMV Inc. (Formerly Immunovaccine Inc.) Announces Q1 2018 Financial Results

HALIFAX, Nova Scotia, May 14, 2018 (GLOBE NEWSWIRE) -- IMV Inc. (TSX:IMV) (OTCQX:IMMVD), a ...

author_avatar
NASDAQ Market News